Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials
Author:
Dorothea E. Myers,James D. Irvin,Ron S. Smith,Virginia M. Kuebelbeck,Fatih M. Uckun
Publication:
Journal of Immunological Methods
Copyright © 1991 Published by Elsevier B.V.